EPAM vs NVDA

EPAM presents a classic value trap profile: fundamentally sound but technically broken. With a Piotroski F-Score of 4/9 (Stable) and a negligible Debt/Equity ratio of 0.04, the company is financially healthy, yet the stock is in a severe multi-year downtrend (-74.1% over 5 years). While the current price of $118.98 sits comfortably below the growth-based intrinsic value of $146.83 and offers an attractive PEG ratio of 0.71, the combination of bearish insider activity and a 0/100 technical trend suggests a lack of immediate catalysts for recovery.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.